Skip to content
Hyper Palace Group

Users Stopping Slimming Injections Regain Weight Far More Rapidly Than Those on Conventional Diets

Image of medical syringe and weighing machine
Obesity treatment often requires ongoing approaches.

New research suggests that individuals who stop using new weight-loss injections like semaglutide or tirzepatide tend to recover reduced body mass much more quickly than those who end traditional lifestyle programs.

Published data in a leading health publication shows that while obese individuals frequently drop about a fifth of their body weight while using the jabs, the mass comes back at an estimated rate of nearly a kilo each month once they quit.

"Users using these treatments should be cognizant of the danger of rapid rebound weight gain when the treatment is stopped," stated lead investigator Dr. Susan Jebb.

This pace of recovery suggests a return to pre-treatment mass in about a year and a half.

Comparing Approaches

The study, which reviewed 37 of studies involving thousands of participants, compared the effects of these new drugs with older methods.

Researchers note that individuals who lose weight through dieting typically experience a slower weight regain—perhaps 100 grams monthly—post-intervention.

The Reason for the Fast Regain

Nutrition scientists suggest the way of the injections explains the heightened regain.

These medications copy a body's own chemical called glucagon-like peptide-1, which moderates hunger.

"Artificially providing the hormone concentrations far above than normal might result in the system to generate a reduced amount of its endogenous GLP-1, and may also diminish sensitivity to its effects," explained Dr. Adam Collins, a dietetics specialist.

"Discontinuation of this medication leads to hunger is no longer kept in check, making excessive eating a significant risk."

An Ongoing Disease?

Medical guidelines recommend the jabs for individuals with obesity-related medical conditions, alongside recommended diet and exercise modifications.

A number of clinicians argue that, given the likelihood of weight regain, the treatment is often ongoing.

This perspective is reinforced by pharmaceutical companies, who state that the results "highlight the chronic nature of excess weight," comparing it to managing conditions like high blood pressure.

User Accounts

Individuals who have discontinued the medication describe a powerful return of hunger.

"It was like a switch activating and you become extremely hungry," described an individual.

This difficulty is compounded if individuals have not adopted lasting dietary or behavioural modifications during therapy.

Significant Use

Survey data indicate that a significant number of people in the UK have used weight-loss jabs in the past year, with interest being substantial.

  • Adoption is greater among females compared to men.
  • The middle-aged age group shows the highest level of interest.
  • A large proportion access the medications through private prescriptions rather than public health services.

In conclusion, experts stress that while these medications are effective tools for shedding pounds, they are not a standalone cure and long-term success relies on combined lifestyle support.

CS
Written by

Cameron Stafford

Aria Vance is a seasoned travel writer and luxury lifestyle expert, with over a decade of experience exploring exclusive destinations and curating bespoke journeys.

Hyper Palace Group

Type to search articles.